Depot Selection and Management Strategy

Determining the best global supply strategy based upon the study design can be a complex discussion involving a number of variables depending upon the study design.

Depot Selection and Management Strategy

As global regulations change, an in-country depot solution versus direct to site shipments from a CMO can greatly impact the success and budget of a trial.

Strategy considerations:

  • Depot oversight including audit requirements (Global Quality Management Systems)
  • Import licence type/requirements and associated timelines
  • Order strategy (including IRT look ahead period / patient dosing)
  • Depot capabilities (S&D, JIT labelling, Returns and Destruction)
  • Stability of product being shipped
  • In country infrastructure

To listen to the audio recording from this Water Cooler Chat, please complete the form below


New call-to-action

Our dedicated team of specialists will be happy to discuss any of your supply strategy questions or concerns. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients